Objectives: Previous studies from our group showed that lipopolysaccharide (LPS) exposure induces several signs of sickness behavior, including a decrease in food consumption, body weight gain, adipsia, and a biphasic effect in tympanic temperature with a first phase of hypothermia, followed by an increased tympanic temperature. LPS can activate a chain of nonspecific host responses, including the immune response, and decreased zinc levels. In addition, there are differences in the immune response between males and females, particularly fever, with sex hormones interfering with body temperature. This study aims to characterize the effects of zinc treatment on tympanic temperature, body weight gain, food and water consumption, and general activity in open field of virgin female rats exposed to a dose of LPS that was previously reported to induce sickness behavior. Methods: Virgin female Wistar rats were treated with either saline (S) or LPS. One hour later, the S group received another injection of saline (S + S group), half of the LPS group received saline (LPS + S group) and the other half received zinc (LPS + Zn group). Tympanic temperature, body weight, and water and food consumption were measured for 96 h. Measurements and observations started 2 h after LPS administration. Results: Treatment with zinc attenuated LPS-increased temperature, decreased the body weight gain and food consumption, and water consumption was increased. Conclusion: Zinc treatment is beneficial as it reduces the increased tympanic temperature induced by LPS, but it does not influence other sickness behavior caused by exposure to LPS.

1.
Dantzer R: Cytokine-induced sickness behavior: mechanisms and implications. Ann NY Acad Sci 2001; 933: 222–234.
2.
Kupferschmid BJ, Therrien B, Rowsey PJ: Different sickness responses in adult and aged rats following lipopolysaccharide administration. Biol Res Nurs 2018; 20: 335–342.
3.
Van Miert AS, Van Duin CT, Verheijden JH, Schotman AJ, Nieuwenhuis J: Fever and changes in plasma zinc and iron concentrations in the goat: the role of leukocytic pyrogen. J Comp Pathol 1984; 94: 543–557.
4.
Dudek K, Bednarek D, Siwicki AK, Rokita E, Studzinski T: The effect of LPS injections on non-specific immune response in affected pigeons. Pol J Vet Sci 2013; 16: 723–729.
5.
Dardenne M: Zinc and immune function. Eur J Clin Nutr 2002; 56(suppl 3):S20–S23.
6.
Ripa S, Ripa R: Zinc and immune function. Minerva Med 1995; 86: 315–318.
7.
Ibs K-H, Rink L: Zinc-altered immune function. J Nutr 2003; 133: 1452S–1456S.
8.
Gammoh NZ, Rink L: Zinc in infection and inflammation. Nutrients 2017; 9:pii: E624.
9.
Costa-Pinto FA, Cohn DWH, Sa-Rocha VM, Sa-Rocha LC, Palermo-Neto J: Behavior: a relevant tool for brain-immune system interaction studies. Ann NY Acad Sci 2009; 1153: 107–119.
10.
Nascimento AF, Alves GJ, Massoco CO, Teodorov E, Felicio LF, Bernardi MM, Bernardi NN: Lipopolysaccharide-induced sickness behavior in lactating rats decreases ultrasonic vocalizations and exacerbates immune system activity in male offspring. Neuroimmunomodulation 2015; 22: 213–221.
11.
Bernardi MM, Teixeira LP, Ligeiro-de-Oliveira A, Tavares-de-Lima W, Palermo-Neto J, Kirsten TBT, et al: Neonatal lipopolysaccharide exposure induces sexually dimorphic sickness behavior in adult rats. Psychol Neurosci 2014; 7: 113–123.
12.
Kirsten TB, Chaves-Kirsten GP, Bernardes S, Scavone C, Sarkis JES, Bernardi MM, et al: Lipopolysaccharide exposure induces maternal hypozincemia, and prenatal zinc treatment prevents autistic-like behaviors and disturbances in the striatal dopaminergic and mTOR systems of offspring. PLoS One 2015; 10:e0134565.
13.
Summers BL, Rofe AM, Coyle P: Prenatal zinc treatment at the time of acute ethanol exposure limits spatial memory impairments in mouse offspring. Pediatr Res 2006; 59: 66–71.
14.
Nascimento A, Bernardi M, Pecorari V, Massoco C, Felicio L: Temporal analysis of lipopolysaccharide-induced sickness behavior in virgin and lactating female rats. Neuroimmunomodulation 2013; 20: 305–312.
15.
Romanovsky AA, Kulchitsky VA, Simons CT, Sugimoto N: Methodology of fever research: why are polyphasic fevers often thought to be biphasic? Am J Physiol 1998; 275:R332–R338.
16.
Romanovsky AA, Almeida MC, Aronoff DM, Ivanov AI, Konsman JP, Steiner AA, et al: Fever and hypothermia in systemic inflammation: recent discoveries and revisions. Front Biosci 2005; 10: 2193–2216.
17.
Derijk RH, Van Kampen M, Van Rooijen N, Berkenbosch F: Hypothermia to endotoxin involves reduced thermogenesis, macrophage-dependent mechanisms, and prostaglandins. Am J Physiol 1994; 266:R1–R8.
18.
Romanovsky AA, Shido O, Sakurada S, Sugimoto N, Nagasaka T: Endotoxin shock: thermoregulatory mechanisms. Am J Physiol 1996; 270:R693–R703.
19.
Clemmer TP, Fisher CJ, Bone RC, Slotman GJ, Metz CA, Thomas FO: Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med 1992; 20: 1395–1401.
20.
Liu E, Lewis K, Al-Saffar H, Krall CM, Singh A, Kulchitsky VA, et al: Naturally occurring hypothermia is more advantageous than fever in severe forms of lipopolysaccharide- and Escherichia coli-induced systemic inflammation. AJP Regul Integr Comp Physiol 2012; 302:R1372–R1383.
21.
Ivanov AI, Patel S, Kulchitsky VA, Romanovsky AA: Platelet-activating factor: a previously unrecognized mediator of fever. J Physiol 2003; 553: 221–228.
22.
Marrache AM, Gobeil F Jr, Bernier SG, Stankova J, Rola-Pleszczynski M, Choufani S, et al: Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. J Immunol 2002; 169: 6474–6481.
23.
Hsueh W, Gonzalez-Crussi F, Arroyave JL: Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. FASEB J 1987; 1: 403–405.
24.
Libert C, Van Molle W, Brouckaert P, Fiers W: α1-Antitrypsin inhibits the lethal response to TNF in mice. J Immunol 1996; 157: 5126–5129.
25.
Nunez D, Kumar K, Hanahan D: Inhibition of (3H)platelet activating factor (PAF) binding by Zn2+: a possible explanation for its specific PAF antiaggregating effects in human platelets. Arch Biochem Biophys 1989; 272: 466–475.
26.
Evangelou A, Kalfakakou V, Benveniste J, Arnoux B: Inhibition of PAF-acether effects on isolated guinea pig hearts by zinc ions (Zn2+). Biol Trace Elem Res 1995; 50: 43–55.
27.
Sessler DI: Mild perioperative hypothermia. N Engl J Med 1997; 336: 1730–1737.
28.
McCall KA, Huang C-CC, Fierke CA: Function and mechanism of zinc metalloenzymes. J Nutr 2000; 130: 1437–1446.
29.
Christianson DW: Structural biology of zinc. Adv Protein Chem 1991; 42: 281–355.
30.
Coleman JE: Zinc proteins: enzymes, storage proteins, transcription factors, and replication proteins. Annu Rev Biochem 1992; 61: 897–946.
31.
McCall KA, Huang CC, Fierke CA: Function and mechanism of zinc metalloenzymes. J Nutr 2000; 130: 1437S–1446S.
32.
Haase H: Zinc signals and immune function; in Collins J (ed): Molecular, Genetic, and Nutritional Aspects of Major and Trace Minerals, ed 1. Elsevier, 2016, chapt 21, pp 261–271.
33.
Haase H, Rink L: Multiple impacts of zinc on immune function. Metallomics 2014; 6: 1175.
34.
Salgueiro MJ, Zubillaga M, Lysionek A, Cremaschi G, Goldman CG, Caro R, et al: Zinc status and immune system relationship: a review. Biol Trace Elem Res 2000; 76: 193–205.
35.
Haase H, Rink L: Zinc signals and immune function. BioFactors 2014; 40: 27–40.
36.
Shankar AH, Prasad AS: Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 1998; 68: 447S–463S.
37.
Salgueiro MJ, Zubillaga M, Lysionek A, Sarabia MI, Caro R, De Paoli T, et al: Zinc as an essential micronutrient: a review. Nutr Res 2000; 20: 737–755.
38.
Cossack Z: The role of zinc in endotoxin fever. Int J Vitam Nutr Res 1991; 61: 57–60.
39.
Kurugöl Z, Bayram N, Atik T: Effect of zinc sulfate on common cold in children: randomized, double blind study. Pediatr Int 2007; 49: 842–847.
40.
Nascimento AF: Influence of LPS and zinc on interaction mother and offspring (2016). http://www.teses.usp.br/teses/disponiveis/10/10133/tde-04052016-152636/pt-br.php.
41.
Alves GJ, Vismari L, Palermo-Neto J: Cohabitation with a sick cage mate: effects on ascitic form of Ehrlich tumor growth and macrophage activity. Neuroimmunomodulation 2007; 14: 297–303.
42.
Conti B, Tabarean I, Andrei C, Bartfai T: Cytokines and fever. Front Biosci 2004; 9: 1433–1449.
43.
Lenczowski MJP, Bluthé RM, Roth J, Rees GS, Rushforth DA, van Dam A-MM, et al: Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats. Am J Physiol 1999; 276:R652–R658.
44.
Sachot C, Poole S, Luheshi GN: Circulating leptin mediates lipopolysaccharide-induced anorexia and fever in rats. J Physiol 2004; 561: 263–272.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.